Inovio`s proprietaryelectroporation-based DNA vaccine delivery technology has been shown by initialhuman data to safely and significantly increase gene expression and immuneresponses. Inovio`s clinical programs include HPV/cervical cancer (therapeutic)and HIV vaccines An IND has been filed for an avian influenza vaccine. More information is available at This press release contains certain forward-looking statements relating to ourplans to develop electroporation-based drug and gene delivery technologies andDNA vaccines. Partnersand collaborators include Merck, Tripep, University of Southampton, Universityof Pennsylvania, and HIV Vaccines Trial Network. Inovio`s product candidates andtechnologies are protected by an extensive global intellectual propertyportfolio. The company`s SynCon technology enables the design of DNA-basedvaccines capable of providing cross-protection against evolving, unmatchedstrains of pathogens such as influenza. Thursday July 908:30 - 09:05Location: 305BC Immune Therapy by ElectroporationPlenary Session 2Iacob Mathiesen, Ph.D., Managing Director, Inovio AS Thursday July 911:00 - 12:10Location: 305BC Pandemic and Seasonal Influenza DNA Vaccines Delivered via Electroporation Plenary Session 3Niranjan Y Sardesai, Ph.D., Sr.

VP, Research & Development, Inovio Biomedical Thursday July 913:10 - 14:55Location: 305BC Special Considerations for Multi-Component DNA Vaccine ProductionPlenary Session 7Henry Hebel, Chief Operating Officer, VGXI Inc.Friday July 10 11:00 - 12:10Location: 305BCAbout Inovio Biomedical CorporationInovio Biomedical is engaged in the design, development, and delivery of a newgeneration of vaccines, called DNA vaccines, focused on cancers and infectiousdiseases. SAN DIEGO--(Business Wire)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design,development and delivery, announced today that it will make multiplepresentations at the Annual Conference of DNA Vaccines in Asia 2009 being hostedby the International Society of DNA Vaccines July 9 - 10 at the BeijingInternational Convention Center. The conference, with the theme, "Advancing DNAVaccine Technology," is co-chaired by David B. Weiner, Ph.D., professor ofpathology, University of Pennsylvania School of Medicine, and chairman ofInovio`s scientific advisory board.

Inovio scientists and associates will be making the following presentations: Engineering Highly Immune Potent DNA Vaccines by Engineering Molecular Biology, Immunology and Physical Delivery In Vivo Presidential Address and Keynote Lecture David B Weiner, Ph.D. Edney who continued, "I think it is thesame phenomenon that Wal-Mart has experienced, discount retailers are enjoyinga boom season while everyone else is wondering what happened. We have decidedthat now is our time: We are investing in our future by returning all profitsinto our marketing efforts." GoldenAgeMedical.Com is still working on several ads that will begin airing asthe new Fall TV season begins.One thirty-second spot ad is available ontheir website: View the adult diapers TV test ad here.It remains to be seen if this will be an effective strategy.Even Mr. Tony Edney, president of GoldenAgeMedical.Comexplained, "We are not reducing our traditional web marketing efforts at all;we are simply expanding into television advertising in order to broaden ourbranding efforts."The specialty online retailer is attempting to capture market share during therecession as its competitors suffer from weak sales "Our sales volume hasactually been increasing," said Mr. Online retailer, GoldenAgeMedical.Com is pleased to announce a new national TVad campaign that will be running across multiple networks and across a broadspectrum of timeslots, including early evening primetime.CHARLESTON, S.C., July 6 /PRNewswire/ -- GoldenAgeMedical , a leadingonline retailer of adult diapers and other incontinence products, hasannounced a dramatic move into national television advertising in order toboost market share Mr.

All other trademarks are the property of theirrespective owners.Editorial contact:Tieto DeutschlandRolf Lindenberg+49 (0) 40 orOneSpin SolutionsSarah Miller+1 Copyright Business Wire 2009. OneSpin is a registered trademark and OneSpin Solutions, OneSpin 360, the 360 MVproduct names, GapFreeVerification, and the OneSpin logo are trademarks ofOneSpin Solutions GmbH. For further information please visit http:// or email . We specialize inareas where we have the deepest understanding of our customers' businesses andneeds.